Clinical Trials Logo

Clinical Trial Summary

This study compares the standard of care to the standard of care plus the administration of bupivacaine or liposomal bupivacaine in patients receiving craniotomies.


Clinical Trial Description

Objective: To assess the effectiveness of analgesia by scalp nerve block with various agents in the first 72 hours following elective craniotomy. The investigators will employ a randomized, single-blinded, prospective study design. Participants will be randomized 1:1:1 into one of three treatment groups: Bupivacaine, Liposomal Bupivacaine, and Saline. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04749797
Study type Interventional
Source University of Pennsylvania
Contact
Status Terminated
Phase Phase 4
Start date September 2, 2020
Completion date July 20, 2021